Comparative Effectiveness of Levofloxacin-Based Triple Regimen and Standard Clarithromycin-Based Triple Regimen in Eradication of Helicobacter Pylori - Insights from A Peripheral Hospital-Based Study
Abstract
Objective: To compare the effectiveness of a Levofloxacin-based triple regimen with the standardClarithromycin-based triple regimen in eradicating gastric Helicobacter pylori (H. pylori) infection.Study Design: Quasi-experimental study.Place and Duration of Study: This study was conducted at the Department of Medicine, Combined MilitaryHospital (CMH), Sibbi, Pakistan from January 2021 to August 2022.Methods: A total of two hundred and sixty patients (n=260), both male and female, diagnosed with H. pyloriinfection, were enrolled. Patients who had used antibiotics within the past four weeks or proton pumpinhibitors within the past two weeks were excluded to avoid interference with treatment efficacy. Participantswere randomly assigned to two groups: The Levofloxacin Group received levofloxacin, amoxicillin, andomeprazole, while the Clarithromycin Group was treated with clarithromycin, amoxicillin, and omeprazole,each regimen lasting 14 days. After completing the eradication therapy, all patients were assessed for H. pylorieradication using the fecal antigen test.Results: The median age of the participants was 30.00 years (26.00–36.00). Of the patients, 158 (60.8%) werefemale and 102 (39.2%) were male. Post-treatment testing revealed that 209 patients (80.4%) tested negative,indicating successful eradication, while 51 patients (19.6%) remained positive for fecal H. pylori antigen test. Inthe Clarithromycin Group, 96 patients (73.8%) tested negative, compared to 113 patients…
How strong is the evidence?
Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design. Reported size: 260 participants or records.
Read the paper
Related studies
- Ferulic acid regulates the AKT/GSK-3β/CRMP-2 signaling pathway in a middle cerebral artery occlusion animal model
- Novel Pharmacokinetic/Pharmacodynamic Parameters Quantify the Exposure–Effect Relationship of Levofloxacin against Fluoroquinolone-Resistant Escherichia coli
- Photochemical behavior of levofloxacin
- Correlation Between Dissolution Profiles of Salt-Form Drugs in Biorelevant Bicarbonate Buffer and Oral Drug Absorption: Importance of Dose/ Fluid Volume Ratio
- Evaluation of the synergistic potential and mechanisms of action for de novo designed cationic antimicrobial peptides
- Synthesis of [11C]levofloxacin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.